- Home
- AVIR vs AMRN Comparison
AVIR vs AMRN Comparison
Compare AVIR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- AMRN
- Stock Information
- Founded
- AVIR 2012
- AMRN 1989
- Country
- AVIR United States
- AMRN Ireland
- Employees
- AVIR N/A
- AMRN N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AVIR Health Care
- AMRN Health Care
- Exchange
- AVIR Nasdaq
- AMRN Nasdaq
- Market Cap
- AVIR 290.4M
- AMRN 302.0M
- IPO Year
- AVIR 2020
- AMRN 1993
- Fundamental
- Price
- AVIR $3.14
- AMRN $19.10
- Analyst Decision
- AVIR Hold
- AMRN Strong Sell
- Analyst Count
- AVIR 1
- AMRN 1
- Target Price
- AVIR $6.00
- AMRN $12.00
- AVG Volume (30 Days)
- AVIR 399.6K
- AMRN 94.0K
- Earning Date
- AVIR 11-06-2025
- AMRN 10-29-2025
- Dividend Yield
- AVIR N/A
- AMRN N/A
- EPS Growth
- AVIR N/A
- AMRN N/A
- EPS
- AVIR N/A
- AMRN N/A
- Revenue
- AVIR N/A
- AMRN $219,361,000.00
- Revenue This Year
- AVIR N/A
- AMRN N/A
- Revenue Next Year
- AVIR N/A
- AMRN N/A
- P/E Ratio
- AVIR N/A
- AMRN N/A
- Revenue Growth
- AVIR N/A
- AMRN N/A
- 52 Week Low
- AVIR $2.46
- AMRN $7.08
- 52 Week High
- AVIR $4.02
- AMRN $20.43
- Technical
- Relative Strength Index (RSI)
- AVIR 52.91
- AMRN 82.57
- Support Level
- AVIR $2.78
- AMRN $15.24
- Resistance Level
- AVIR $2.94
- AMRN $20.43
- Average True Range (ATR)
- AVIR 0.10
- AMRN 0.80
- MACD
- AVIR 0.04
- AMRN 0.39
- Stochastic Oscillator
- AVIR 90.79
- AMRN 75.82
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.